ArticleJournal of clinical pharmacology2022

Evaluation of the Pharmacokinetics and Safety of a Single Dose of Acalabrutinib in Subjects With Hepatic Impairment.

Yan Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.